findmyKOL

Preeti Manavalan, MD

Basic profile

University of Florida

ORCIDNPI
RegionGainesville, FL · SoutheastSpecialtyInfectious DiseaseFocusInfectious Disease
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceNot yet checkedPaymentsNone reportedNIH funding2023–2026Why? →

Preeti Manavalan is an Infectious Disease physician affiliated with University of Florida. OpenAlex indexes 40 publications with 364 citations (h-index 11).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
40publications

Distinct works indexed by OpenAlex, matched via ORCID.

364citations

Total citations across indexed works.

11h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
2NIH grants · 2023–2026

Federally funded research awards.

View funding

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Anti-infectives

    86.7%
    Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor39.8%
    Dovato53%Tivicay47%
    Part D<11 patients
    Protease Inhibitor15.9%
    Prezcobix43%Prezista29%Ritonavir29%
    Part D<11 patients

    + 4 more classes in this area

  • Cardiovascular

    8%
    Statin8%
    Atorvastatin Calcium100%
    Part D<11 patients
  • Respiratory

    5.3%
    beta2-Adrenergic Agonist5.3%
    Albuterol Sulfate Hfa100%
    Part D<11 patients
Where care is delivered (Part B)28.2% facility · 71.8% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

2 NIH research awards on record, funded 20232026 per NIH RePORTER. The latest:

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”